Another course taught by Steve Casper (see ALS359).
This course will equip students with tools to effectively
understand global marketplace issues within the life sciences. The course has three broad aims. First, students will learn how to assess
bioscience market opportunities within different regions of the world,
including advanced economies in East Asia and Europe and rapidly emerging
marketplaces such as China and India.
Second, students will explore the causes and consequences of
globalization, focusing on the increased ability of firms, both small and
large, to develop global value chains that integrate research, development and
other marketplace activities from regions around the world. Finally, the course will explore global
health issues, exploring a variety of policy perspectives oriented towards
creating drugs for neglected diseases.
Learning Objectives
- Become familiar with analytic tools to assess bioscience related market opportunities within developed and emerging economies.
- Evaluate how differences in the structure of national and regional economies impact how companies from different areas of the world develop competitive strategies.
- Explore the development of global value chains in the pharmaceutical and other bioscience related industries and understand typical managerial problems they create.
- Understand the causes of global health problems in different disease areas and different regions of the world, and become familiar with long-standing population-based and clinical approaches to combating global health problems.
- Evaluate new approaches to drug development towards neglected diseases, including public-private partnerships, non-profit pharmaceutical companies, and company oriented approaches.
- Development of professional skills – teamwork, project management, and both written and spoken forms of communication.
Course Assessment:
Short quizzes (3 x 5% each) 15%
Mid-term exam
25%
Global health team project 25%
Class participation 35%
Short quizzes: Three short quizzes (15 minutes) are designed
to ensure that students have a firm grasp of core concepts surrounding national
competitiveness and patterns of globalization.
Final exam. This will be a case-based exam, drawing
primarily on international business issues examined during the second half of
the course. The exam will be open book.
Market assessment
project: Teams of 4-6 students will
examine biotechnology investment opportunities within an emerging biotechnology
country marketplace. Students will assume
the role of an analyst for a venture capital firm charged with evaluating new
investment opportunities. Teams must
chose one country and explore relevant aspects of market and regulatory
conditions in this country pertaining to a specific bioscience related
investment opportunity in that country.
Project deliverables will include a written executive summary and 20
minute Powerpoint style presentation.
More detailed instructions will be distributed in class.
Course Materials
All Harvard Business School cases readings should be
purchased in a reader available at the Huntley Bookstore. Due to strict copyright enforcement by
Harvard Business School, purchasing the casebook is mandatory for this
class. Unauthorized copying of HBS cases
for use in this class will be treated as a KGI honor code violation.
Students should also buy the following book from the Huntley
Bookstore (or order it on-line).
Pankaj Ghemawat, Redefining
Global Strategy, Harvard Business School Press, 2007
All other readings, including several KGI case readings
developed especially for this course, will be available on the Sakai
system.
No comments:
Post a Comment